Oncocentro de Minas Gerais

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Ovarian cancer2 trials

Phase

• Phase 33 trials

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Not yet recruiting1 trial

Lead sponsor

• Eli Lilly and Company3 trials
• Latin American Cooperative Oncology Group1 trial

Running trials

• Not yet recruiting

  Molecular Ovarian Cancer Assessment in LatiNoAmerican PAtients

  NCT07771400· Latin American Cooperative Oncology Group· Source

  Contact: Angélica Rodrigues

• Recruiting

  A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  NCT07213804· Phase 3· Eli Lilly and Company· Source

  Contact: Angelica Rodrigues (principal investigator)

• Recruiting

  Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

  NCT06890598· Phase 3· Eli Lilly and Company· Source

  Contact: Flavia Duarte (principal investigator)

• Active, not recruiting

  A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

  NCT04819100· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Ovarian cancer2 recruiting
• Lung cancer1 recruiting